Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock
Cytokinetics priced an upsized public offering of 9.86 million shares at $71.00 per share, expecting gross proceeds of approximately $700 million. The deal includes a 30-day option for underwriters to purchase an additional 1.48 million shares and is expected to close on May 8, 2026. Morgan Stanley, Goldman Sachs, J.P.
Key figures
- Deal Value Usd
- 700000000
- Offering Price
- 71
- Shares Offered
- 9859155
- Overallotment shares
- 1478873
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.